NEW Release Clinical Content
Newly released clinical papers. If you’d like to place an order for reprints or ePrints, as listed below or otherwise, please reach out to your usual HME contact or email reprints@wearehme.com for a quote.
ONCOLOGY New England Journal of Medicine RELEASED September 2020
Dummer R et al
Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma.
ONCOLOGY Immunotherapy RELEASED September 2020
Bersanelli M et al
Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy
ONCOLOGY European Journal of Oncology Nursing RELEASED August 2020
Caruso R et al
Comment on "pathways to psychological wellbeing for patients with bladder cancer and their partners-in-care" and contextualization in the COVID-19 pandemic
ONCOLOGY Jnl of Oncology Pharmacy Practice RELEASED August 2020
Godsfavour O Umoru et al
Evaluation of efficacy and safety of pegfilgrastim when given less than two weeks from dose-dense chemotherapy regimens.
ONCOLOGY Jnl of Oncology Pharmacy Practice RELEASED June 2020
Harvey R D et al
Afatinib for the treatment of EGFR mutation-positive NSCLC: A review of clinical findings.
ONCOLOGY Jnl of Oncology Pharmacy Practice RELEASED July 2020
Bauters T et al
Optimizing care for high-risk neuroblastoma patients treated with dinutuximab: Challenges for the multidisciplinary team
CARDIOLOGY New England Journal of Medicine AHEAD of PRINT August 2020
MIlton Packer et al
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
CARDIOLOGY New England Journal of Medicine AHEAD of PRINT August 2020
Okumura K et al
Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation
|
